CompanyGraph
What stands out
- Most companies in its industry are production businesses; this one is a flow business
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleRevenue is $3.36B, above the global median of $548.88M
- PositionCurrent ratio is 1.12×, lower than 95% of its Medical Devices peers (median 3.87×)
- Interpretations2 currently firing — 2
What this company is and how it runs — written from structure, not news.
What stands out
- Most companies in its industry are production businesses; this one is a flow business
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
767.35MUSDvs all stocks (USD)
Revenue (TTM)
3.36BUSDvs all stocks (USD)
Profit Margin
-6.79%vs Medical Devices peers
Beta
1.39xvs all stocks
52-Week Change
-35.02%vs all stocks
Market Capitalization
767.35MUSDvs all stocks (USD)
Enterprise Value
2.78BUSDvs all stocks (USD)
Forward P/E
-45.48xvs Medical Devices peers
Price to Sales (TTM)
0.2281xvs Medical Devices peers
Price to Book (MRQ)
0.5457xvs Medical Devices peers
Enterprise to Revenue
0.8270xvs Medical Devices peers
Enterprise to EBITDA
4.77xvs Medical Devices peers
Profit Margin
-6.79%vs Medical Devices peers
Operating Margin
0.84%vs Medical Devices peers
Return on Assets (TTM)
2.28%vs Medical Devices peers
Return on Equity (TTM)
-15.22%vs Medical Devices peers
Revenue (TTM)
3.36BUSDvs all stocks (USD)
Revenue per Share (TTM)
24.79USDUpdated Sep 26, 2026Quarterly Revenue Growth
12.70%vs Medical Devices peers
Gross Profit (TTM)
644.93MUSDvs all stocks (USD)
EBITDA (TTM)
528.64MUSDvs all stocks (USD)
Net Income (TTM)
-231.10MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-4.10%vs Medical Devices peers
Operating Cash Flow (TTM)
583.27MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-80.69MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 26, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
7.76MUSDFY2025 · Dec 31, 2025Revenue
3.24BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
2.64BUSDFY2025 · Dec 31, 2025Gross Profit
609.20MUSDFY2025 · Dec 31, 2025Operating Income
186.27MUSDvs all stocks (USD)
Pre-tax Income
-15.15MUSDFY2025 · Dec 31, 2025Income Tax Expense
50.88MUSDFY2025 · Dec 31, 2025Net Income
-66.04MUSDFY2025 · Dec 31, 2025EBIT
90.60MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
567.92MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
382.29MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
105.75MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.5200USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.5200USDFY2025 · Dec 31, 2025Basic Shares Outstanding
135.15MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
135.15MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-66.04MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
-4.76MUSDFY2025 · Dec 31, 2025Operating Cash Flow
567.45MUSDFY2025 · Dec 31, 2025Free Cash Flow
185.06MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
106.14MUSDFY2025 · Dec 31, 2025Income Tax Paid
24.28MUSDFY2025 · Dec 31, 2025Interest Paid
101.24MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-66.04MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
381.93MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
47.16MUSDFY2025 · Dec 31, 2025Stock-based Compensation
21.88MUSDFY2025 · Dec 31, 2025Other Non-cash Items
54.87MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
30.99MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
96.66MUSDFY2025 · Dec 31, 2025Capital Expenditures
-382.39MUSDFY2025 · Dec 31, 2025Net Acquisitions
78.04MUSDFY2025 · Dec 31, 2025Purchase of Investments
0.00USDFY2025 · Dec 31, 2025Other Investing Activity
1.16MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-303.19MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-268.48MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
0.00USDFY2025 · Dec 31, 2025Other Financing Charges
-34.92MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-303.40MUSDFY2025 · Dec 31, 2025Shares Outstanding
133.37MSharesUpdated Sep 26, 2026Float Shares
85.77MSharesUpdated Sep 26, 2026Shares Short
9.63MSharesUpdated Sep 26, 2026Short Ratio
3.45daysvs all stocks
Short % of Shares Outstanding
9.61%vs all stocks
% Held by Insiders
8.28%vs all stocks
% Held by Institutions
108.51%vs all stocks
Total Cash (MRQ)
43.29MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.3240USDUpdated Sep 26, 2026Total Debt (MRQ)
2.07BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
1.49xvs Medical Devices peers
Current Ratio (MRQ)
1.12xvs Medical Devices peers
Book Value per Share (MRQ)
10.34USDUpdated Sep 26, 2026Total Assets
4.32BUSDvs all stocks (USD)
Total Current Assets
728.90MUSDFY2025 · Dec 31, 2025Total Liabilities
2.79BUSDFY2025 · Dec 31, 2025Total Non-current Assets
3.59BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
2.08BUSDFY2025 · Dec 31, 2025Total Current Liabilities
712.39MUSDFY2025 · Dec 31, 2025Cash
106.14MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
106.14MUSDFY2025 · Dec 31, 2025Accounts Receivable
370.90MUSDFY2025 · Dec 31, 2025Inventory
151.25MUSDFY2025 · Dec 31, 2025Accounts Payable
352.38MUSDFY2025 · Dec 31, 2025Short-term Debt
68.74MUSDFY2025 · Dec 31, 2025Deferred Revenue
59.84MUSDFY2025 · Dec 31, 2025Other Current Liabilities
30.11MUSDFY2025 · Dec 31, 2025Long-term Debt
1.83BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
243.80MUSDFY2025 · Dec 31, 2025Common Stock (Book)
13.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-632.97MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
1.53BUSDvs all stocks (USD)
Treasury Stock
25.55MUSDFY2025 · Dec 31, 202552-Week Low
5.21USDUpdated Sep 26, 202652-Week High
13.43USDUpdated Sep 26, 202652-Week Change
-35.02%vs all stocks
Beta
1.39xvs all stocks
50-Day MA
7.14USDUpdated Sep 26, 2026200-Day MA
9.74USDUpdated Sep 26, 2026Avg 10-Day Volume
2.82MSharesUpdated Sep 26, 2026Avg 30-Day Volume
2.73MSharesUpdated Sep 26, 2026Diluted EPS (TTM)
-1.71USDUpdated Sep 26, 2026Other Income / Expense
-95.67MUSDFY2025 · Dec 31, 20252 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 1.12×, lower than 95% of its Medical Devices peers (median 3.87×)Significant
Current ratio: 1.12Industry median: 3.87Industry P5: 1.33Peers compared: 102
Debt-to-equity is 1.49×, higher than 95% of its Medical Devices peers (median 0.11×)Significant
Debt-to-equity: 1.49Industry median: 0.11Industry P95: 1.28Peers compared: 102
Price-to-book is 0.55×, lower than 95% of its Medical Devices peers (median 2.51×)Notable
Price-to-book: 0.55Industry median: 2.51Industry P5: 0.60Peers compared: 102
Structural Tensions
Most companies in its industry are production businesses; this one is a flow businessSignificant
Industry peers: 174Share on the common pattern %: 98.00
Financial Health
Altman Z-Score 0.78: distress zoneCritical
Altman Z-Score: 0.78
High earnings qualityNotable
Earnings Quality Score: 3.20
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Revenue is $3.36B, above the global median of $548.88MNotable
Revenue (USD): 3,363,389,952Global Median: 548,883,780.48
Companies that share the same coordination system — how they create, deliver, or capture value.
Lumexa Imaging Holdings, Inc.
Tier 1FlowApproval-Gated PipelineInterfaceRule
Nanjing Pharmaceutical Co., Ltd.
Tier 1FlowApproval-Gated PipelineInterfaceRule
Iridium Corporation
Tier 1FlowApproval-Gated PipelineProduction
Dimed S.A. Distribuidora de Medicamentos
Tier 1FlowApproval-Gated PipelineInterfaceRule
Viemed Healthcare Inc.
Tier 1FlowApproval-Gated PipelineProductionRule
Hyundai Movex Co., Ltd.
Tier 1FlowApproval-Gated PipelineProductionRisk
Finnair Oyj
Tier 3FlowPerishable CapacityProductionRisk
Ryoyo Ryosan Holdings Inc.
Tier 3FlowThroughput-Bound ConversionRiskInterface
Anhui Zhonghuan Environment Protection Co., Ltd.
Tier 3FlowRegulated Return InfrastructureRuleProduction
SBS Transit Ltd.
Tier 3FlowThroughput-Bound ConversionProductionInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
2 interpretationsDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Md Entertainment Tbk
2 interpretationsDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Wintao Communications Co.
2 interpretationsDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated